Posts

STAT+: Startup Alumis raises $259 million as it prepare...

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big p...

STAT+: With Meta’s backing, Headspace launches into VR

Headspace XR, developed with funding from Meta, guides users through meditation ...

Florida health officials provide scant details on measl...

Health experts are expressing concern about a dearth of information about the me...

STAT+: Republicans consider a new attack on Biden ‘marc...

Biden has taken aim at drug patents with a "march-in" rights idea. Republicans a...

STAT+: Oracle Health chair says Cerner isn’t competing ...

Cerner's new owner aims to win customers with cloud services instead of just ele...

Opinion: Charging patients to message their doctors mos...

Charging patients to message doctors won’t reduce physicians’ inbox burden or pr...

Air quality improvements belie rising racial and ethnic...

Our air is getting cleaner. But the relative toll of pollutants on communities o...

STAT+: FDA clears first over-the-counter continuous glu...

The agency Tuesday authorized Dexcom to start selling a new product, called the ...

STAT+: Large insurers say up to one-quarter of claims r...

CVS and other insurers said up to 25% of their claims are run through Change Hea...

FDA advisory panel recommends a streamlined flu vaccine...

When Americans line up for flu vaccines next fall, they will likely be getting v...

STAT+: Harvard longevity scientist sparks furor with cl...

Harvard longevity researcher David Sinclair recently made an astonishing asserti...

It’s time to stop treating menopause like a disease, re...

About 50 million women enter menopause every year. A new essay published in The ...

STAT+: WTO proposal for Covid diagnostics and therapeut...

The WTO failed to adopt a controversial proposal to waive intellectual property ...

Where’s Lilly’s Alzheimer’s approval?

Eli Lilly’s treatment for Alzheimer’s was up for a sure-thing FDA approval in Q4...

GZ17-6.02 with proteasome inhibitors kills multiple mye...

“We believe that developing GZ17-6.02 as a novel multiple myeloma agent potentia...

NRL researcher awarded grant to study nanotechnology se...

WASHINGTON  –  U.S. Naval Research Laboratory (NRL) research chemist, Braden C. ...